163 related articles for article (PubMed ID: 27604270)
81. Hepatic metabolism of licochalcone A, a potential chemopreventive chalcone from licorice (Glycyrrhiza inflata), determined using liquid chromatography-tandem mass spectrometry.
Huang L; Nikolic D; van Breemen RB
Anal Bioanal Chem; 2017 Dec; 409(30):6937-6948. PubMed ID: 29127460
[TBL] [Abstract][Full Text] [Related]
82. Drug-Drug Interaction Potentials of Tyrosine Kinase Inhibitors via Inhibition of UDP-Glucuronosyltransferases.
Zhang N; Liu Y; Jeong H
Sci Rep; 2015 Dec; 5():17778. PubMed ID: 26642944
[TBL] [Abstract][Full Text] [Related]
83. Urinary Elimination of Bile Acid Glucuronides under Severe Cholestatic Situations: Contribution of Hepatic and Renal Glucuronidation Reactions.
Perreault M; Wunsch E; Białek A; Trottier J; Verreault M; Caron P; Poirier GG; Milkiewicz P; Barbier O
Can J Gastroenterol Hepatol; 2018; 2018():8096314. PubMed ID: 29850459
[TBL] [Abstract][Full Text] [Related]
84. Liquid chromatography-mass spectrometric multiple reaction monitoring-based strategies for expanding targeted profiling towards quantitative metabolomics.
Guo B; Chen B; Liu A; Zhu W; Yao S
Curr Drug Metab; 2012 Nov; 13(9):1226-43. PubMed ID: 22519369
[TBL] [Abstract][Full Text] [Related]
85. Regulation of human UDP-glycosyltransferase (
Hu DG; Mackenzie PI; Hulin JA; McKinnon RA; Meech R
Drug Metab Rev; 2022 May; 54(2):120-140. PubMed ID: 35275773
[TBL] [Abstract][Full Text] [Related]
86. Characterization of Clofazimine Metabolism in Human Liver Microsomal Incubation
Howlader S; Kim MJ; Jony MR; Long NP; Cho YS; Kim DH; Shin JG
Antimicrob Agents Chemother; 2022 Oct; 66(10):e0056522. PubMed ID: 36190267
[TBL] [Abstract][Full Text] [Related]
87. Quantification of human uridine-diphosphate glucuronosyl transferase 1A isoforms in liver, intestine, and kidney using nanobore liquid chromatography-tandem mass spectrometry.
Harbourt DE; Fallon JK; Ito S; Baba T; Ritter JK; Glish GL; Smith PC
Anal Chem; 2012 Jan; 84(1):98-105. PubMed ID: 22050083
[TBL] [Abstract][Full Text] [Related]
88.
Jang SN; Park SY; Lee H; Jeong H; Jeon JH; Song IS; Kwon MJ; Liu KH
Xenobiotica; 2021 Oct; 51(10):1087-1094. PubMed ID: 34338601
[TBL] [Abstract][Full Text] [Related]
89. A fluorescence-based microplate assay for high-throughput screening and evaluation of human UGT inhibitors.
Zhou QH; Lv X; Tian ZH; Finel M; Feng L; Huo PC; Zhu YD; Lu Y; Hou J; Ge GB
Anal Chim Acta; 2021 Apr; 1153():338305. PubMed ID: 33714444
[TBL] [Abstract][Full Text] [Related]
90. Drug interaction study of natural steroids from herbs specifically toward human UDP-glucuronosyltransferase (UGT) 1A4 and their quantitative structure activity relationship (QSAR) analysis for prediction.
Xu M; Dong P; Tian X; Wang C; Huo X; Zhang B; Wu L; Deng S; Ma X
Pharmacol Res; 2016 Aug; 110():139-150. PubMed ID: 27208893
[TBL] [Abstract][Full Text] [Related]
91. A combined strategy of mass fragmentation, post-column cobalt complexation and shift in ultraviolet absorption spectra to determine the uridine 5'-diphospho-glucuronosyltransferase metabolism profiling of flavones after oral administration of a flavone mixture in rats.
Li Q; Wang L; Dai P; Zeng X; Qi X; Zhu L; Yan T; Wang Y; Lu L; Hu M; Wang X; Liu Z
J Chromatogr A; 2015 May; 1395():116-28. PubMed ID: 25892633
[TBL] [Abstract][Full Text] [Related]
92. Plasma extracellular nanovesicle (exosome)-derived biomarkers for drug metabolism pathways: a novel approach to characterize variability in drug exposure.
Rowland A; Ruanglertboon W; van Dyk M; Wijayakumara D; Wood LS; Meech R; Mackenzie PI; Rodrigues AD; Marshall JC; Sorich MJ
Br J Clin Pharmacol; 2019 Jan; 85(1):216-226. PubMed ID: 30340248
[TBL] [Abstract][Full Text] [Related]
93. Challenges and recommendations in developing LC-MS/MS bioanalytical assays of labile glucuronides and parent compounds in the presence of glucuronide metabolites.
Yuan L; Sophia Xu X; Ji QC
Bioanalysis; 2020 May; 12(9):615-624. PubMed ID: 32441529
[TBL] [Abstract][Full Text] [Related]
94. Natural and synthetic inhibitors of UDP-glucuronosyltransferase.
Grancharov K; Naydenova Z; Lozeva S; Golovinsky E
Pharmacol Ther; 2001 Feb; 89(2):171-86. PubMed ID: 11316519
[TBL] [Abstract][Full Text] [Related]
95. Separation of four glucuronides in a single sample by high-pressure liquid chromatography and its use in the determination of UDP glucuronosyltransferase activity toward four aglycones.
Liu Z; Franklin MR
Anal Biochem; 1984 Nov; 142(2):340-6. PubMed ID: 6442104
[TBL] [Abstract][Full Text] [Related]
96. Inhibitory effects of Kampo medicine on human UGT2B7 activity.
Nakagawa N; Katoh M; Yoshioka Y; Nakajima M; Yokoi T
Drug Metab Pharmacokinet; 2009; 24(6):490-9. PubMed ID: 20045984
[TBL] [Abstract][Full Text] [Related]
97. Strategies for large-scale targeted metabolomics quantification by liquid chromatography-mass spectrometry.
Zhou J; Yin Y
Analyst; 2016 Nov; 141(23):6362-6373. PubMed ID: 27722450
[TBL] [Abstract][Full Text] [Related]
98. Bioanalytical challenges and strategies for accurately measuring acyl glucuronide metabolites in biological fluids.
Patel SR
Biomed Chromatogr; 2020 Jan; 34(1):e4640. PubMed ID: 31256423
[TBL] [Abstract][Full Text] [Related]
99. Identification and determination of glucuronides and their aglycones in Erigeron breviscapus by liquid chromatography-tandem mass spectrometry.
Qu J; Wang Y; Luo G; Wu Z
J Chromatogr A; 2001 Sep; 928(2):155-62. PubMed ID: 11587333
[TBL] [Abstract][Full Text] [Related]
100. New Perspectives on Acyl Glucuronide Risk Assessment in Drug Discovery: Investigation of In vitro Stability, In situ Reactivity, and Bioactivation.
Gunduz M; Argikar UA; Cirello AL; Dumouchel JL
Drug Metab Lett; 2018; 12(2):84-92. PubMed ID: 29886840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
